Foreword
The Annals of Health Law and Life Sciences Editorial Board is
proud to present the Winter 2022 Issue, the first edition of our thirtyfirst volume to date. Each year, our Editorial Board seeks out articles
covering important and contemporary topics within the health law and
life sciences community. Due to the global COVID-19 pandemic, the
years 2020 and 2021 were unprecedented in many respects, and doubly
so in the health and life sciences spaces. Although the pandemic
significantly impacted many aspects of our lives, scholarship
persevered and has become more important than ever to continue to be
offered.
The health care and life sciences matters addressed in the Winter
2022 Issue particularly further the Annals tradition of covering a broad
range of current and intriguing topics. These selected pieces contribute
to the continued recognition of Annals of Health Law and Life Sciences
as one of the country’s prominent health and life sciences law and
policy journal. I am honored to introduce the following works of
scholarship, which take a critical look at very pertinent and captivating
issues in health law and life sciences.
Michael Cederblom’s article, Welcome to the Digital Age:
Reinventing Contact Tracing and the Public Health Service Act for a
Modern Pandemic Response, starts with a discussion about current
United States law regarding contact tracing during an infectious
disease outbreak. He then explains how the government’s inefficient
response should have had a greater focus on contact tracing and spread
reduction. Cederblom transitions from a discussion about the United
States to China and South Korea to exemplify how a focus on contact
tracing can help control the spread of COVID-19. Specifically, he uses
these examples to show that contact tracing is critical in eliminating an
infectious outbreak in the United States. Cederblom then mentions that
decentralized contact tracing is ineffective. As a solution, he argues
that centralized contact tracing is efficient, but understands that there
is a Fourth Amendment hurdle. Cederblom goes on to propose an
amendment to current United States legislation for greater
transparency while maintaining privacy protections. Cederblom
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concludes that a focus on contact tracing and “creating a highly
controlled, centralized system designed to supplement state contact
tracing efforts” will play a crucial role in future public health
responses.
The second article, Healthcare Fraud Investigations: Overview of
Overbroad Investigative Regime and Recommendations for a More
Targeted Approach, shifts from a focus on the pandemic to a longerlasting topic, healthcare fraud and abuse. Salvatore Filippello focuses
on the currently flawed healthcare fraud and abuse investigation
system and how improvements can be made to help make this system
more efficient. He begins with a discussion about the Affordable Care
Act’s anti-fraud tools and its effects on providers. Filippello also
provides a brief summary on the Anti-Kickback statute, Stark law,
False Claims Act, and other fraud and abuse statutes. He then focuses
on the incentives for relators to bring a fraud and abuse claim and the
effects on providers. Specifically, Filippello provides examples of how
current enforcement has placed a burden on both providers and the
healthcare system. He then transitions to focus on examples of fraud
and abuse that the Department of Justice should be targeting, like passthrough labs, insurance companies, and unnecessary procedures. In
conclusion, Filippello recommends that the Department of Justice
should focus on target areas that need to be further investigated by
considering a patient-centered approach, physician intent, False
Claims Act reform, and implementing a monetary threshold.
Finally, Laura Montesantos closes with Physician Liability in the
Age of Data Reliance and Errors. In her article, Montesantos focuses
on the legal complications that accompany health care innovation and
specifically the lack of clear standards to establish liability for errors.
She begins with a discussion regarding existing legislation and the
focus on technical standards. Montesantos then provides an in-depth
description of how health care data becomes a part of patient records,
exploring the probability of technological errors. She then discusses
the existing legal theories surrounding product liability and medical
malpractice, and reviews if it would be beneficial to use the current
law or provide modifications. Lastly, Montesantos proposes new
federal legislation that focuses on closing the gap on liability,
specifically developing a standard of care for claims of liability and a
three-prong test to determine software and physician responsibility.
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The new standard of care would be for all software manufacturers
regarding product liability. Additionally, under the three-prong test,
physicians would still be held liable for their negligence, but not for
the software defects. Overall, Montesantos concludes that a new
federal standard should balance the growth of healthcare technological
innovation and technology liability in order to promote safe and
effective innovation.
On behalf of all staff members of Annals of Health Law and Life
Sciences, I would like to thank Michael Cederblom, Salvatore
Filippello, and Laura Montesantos for honoring Annals with their
incredible works of scholarship. This issue exemplifies the passion,
dedication, and professionalism of everyone involved. The Editorial
Board and I would like to thank each Associate Editor for their
attentiveness, patience, and enthusiasm during the editing process.
Additionally, I would like to recognize the exceptional work of Edwin
Caro, Annals Publications Editor, for his unwavering commitment to
this journal and its authors. Additionally, I must recognize the
outstanding work of our Symposium Editor and Technical Production
Editor, Abigail Higgins, as well as our Marketing & Coordinating
Editor and Technical Production Editor, Joshua Wiedner, who
continue to go beyond the call of their roles to ensure this journal’s
excellence. I would also like to thank our Advance Directive Editors,
Mambwe Mutanuka and Sarah Ryan, whose untiring efforts have
brought this issue to life. Furthermore, I would like to recognize and
thank our remarkable Senior Editors: Cristal Nova, Luke Cummings,
Eileen Gabriel, and Michael Kemel for their excellent work through
the editing process. And finally, I would like to thank our supportive
advisors at the Beazley Institute for Health Law and Policy, including
Professors Nadia Sawicki and Kristin Finn, for their continued
guidance and support for this issue and its purpose.
Meera V. Patel, Editor-in-Chief

